<DOC>
	<DOCNO>NCT00132678</DOCNO>
	<brief_summary>The purpose study determine risperidone effective safe prevention mood episodes patient bipolar 1 disorder .</brief_summary>
	<brief_title>A Study Safety Efficacy Injectable Risperidone Prevention Bipolar Mood Episodes</brief_title>
	<detailed_description>RISPERDAL CONSTA ( risperidone long-acting injection ) may provide substantial improvement , reduce patient non-compliance , long-term treatment bipolar I disorder . This randomized ( patient assign different treatment base chance ) , double-blind , ( neither patient physician know whether drug placebo take , dosage ) placebo-controlled study explore safety effectiveness RISPERDAL CONSTA prevention mood episodes patient bipolar 1 disorder . This study include 5 period : screening period last 1 week ; open-label RISPERDAL ( oral risperidone ) treatment period last 3 week ; open-label RISPERDAL CONSTA stabilization period last 26 week ; double-blind period last 24 month ; open-label extension RISPERDAL CONSTA last 8 week . Efficacy assess use Young Mania Rating Scale ( YMRS ) , Montgomery-Ã…sberg Depression Rating Scale ( MADRS ) , Clinical Global Impressions - Severity ( CGI-S ) scale , Medical Outcomes Study Short Form 36 ( SF-36 ) , Personal Social Performance ( PSP ) scale . Safety evaluate throughout study include assessment adverse event , clinical laboratory test ( include hematology , serum chemistry , blood glucose/lipid profile , prolactin , urinalysis ) ; electrocardiogram ( ECGs ) , vital sign ( pulse blood pressure ) , physical examination , body mass index ( BMI ) , Extrapyramidal Symptom Rating Scale ( ESRS ) . Oral risperidone ( flexible dosage ) 1 6 mg/day first 3 week . Risperidone LAI i.m . injection ( 12.5mg , 25 mg , 37.5 mg , 50 mg ) give every 2 week approximately 2.6 year ( 6 month patient receive placebo DB-period )</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnosis bipolar 1 disorder , currently experience mixed manic episode stable Two bipolar mood episode last 2 year exclude current episode Negative pregnancy test History &gt; 4 mood episode year last two year patient experience depressive episode History antisocial borderline personality illness Has unstable serious general medical illness Has receive medication disallow study criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Mood episode</keyword>
	<keyword>Bipolar 1 disorder</keyword>
	<keyword>Intramuscular Injectable</keyword>
	<keyword>risperidone</keyword>
	<keyword>safety efficacy</keyword>
</DOC>